Biosig Stock Story

BSGM -  USA Stock  

USD 1.12  0.10  8.20%

Biosig Technologies Working Capital is relatively stable at the moment as compared to the past year. The company's current value of Working Capital is estimated at 26.14 Million. Book Value per Share is expected to hike to 0.94 this year, although the value of Earnings before Tax will most likely fall to (53.6 M). If you have been following Biosig you may be considering acquiring. Let's check if steady technical and fundamental indicators will continue to push the price to hike for Biosig Technologies' stakeholders. The company current odds of distress is under 47 percent. Will stakeholders continue to be optimistic, or should we expect a sell-off?
Published over three months ago
View all stories for Biosig Technologies | View All Stories
How steady are Biosig Technologies (NASDAQ:BSGM) fundamentals?
The firm shows a Beta (market volatility) of 0.3818, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Biosig's beta means in this case. As returns on the market increase, Biosig Technologies returns are expected to increase less than the market. However, during the bear market, the loss on holding Biosig Technologies will be expected to be smaller as well. Although it is extremely important to respect Biosig Technologies historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Biosig Technologies technical indicators, you can presently evaluate if the expected return of 0.0048% will be sustainable into the future. Biosig Technologies right now shows a risk of 6.34%. Please confirm Biosig Technologies jensen alpha, as well as the relationship between the potential upside and skewness to decide if Biosig Technologies will be following its price patterns.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Biosig Technologies income statement, its balance sheet, and the statement of cash flows. Potential Biosig Technologies investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Biosig Technologies investors may use each financial statement separately, they are all related. The changes in Biosig Technologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biosig Technologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
The goal of Biosig Technologies fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Biosig Technologies performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Biosig Technologies shares is the value that is considered the true value of the share. If the intrinsic value of Biosig is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Biosig Technologies.
Please read more on our fundamental analysis page.

Watch out for price decline

Please consider monitoring Biosig Technologies on a daily basis if you are holding a position in it. Biosig Technologies is trading at a penny-stock level, and the possibility of delisting is much higher compared to other equities. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as Biosig Technologies stock to be traded above the $1 level to remain listed. If Biosig Technologies stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.

How important is Biosig Technologies's Liquidity

Biosig Technologies financial leverage refers to using borrowed capital as a funding source to finance Biosig Technologies ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Biosig Technologies financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Biosig Technologies's total debt and its cash.

How does Biosig utilize its cash?

To perform a cash flow analysis of Biosig Technologies, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Biosig Technologies is receiving and how much cash it distributes out in a given period. The Biosig Technologies cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Biosig Technologies Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (27.09 Million)

Biosig Technologies Gross Profit

Biosig Technologies Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Biosig Technologies previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Biosig Technologies Gross Profit growth over the last 10 years.
Please check Gross Profit in more details.

What is driving Biosig Technologies Investor Appetite?

Biosig Technologies reported the previous year's revenue of 118 K. Net Loss for the year was (49.21 M) with profit before overhead, payroll, taxes, and interest of 0.

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biosig Technologies has an asset utilization ratio of 11.45 percent. This denotes that the company is making $0.11 for each dollar of assets. An increasing asset utilization means that Biosig Technologies is more efficient with each dollar of assets it utilizes for everyday operations.


Current Assets
31.7 M
Current Assets31.65 Million95.46
Assets Non Current1.13 Million3.41
Goodwill372,2651.12

Will Biosig Technologies new hike continue?

Maximum drawdown is down to 34.37. It may denote a possible volatility pull down. Biosig Technologies is displaying above-average volatility over the selected time horizon. Investors should scrutinize Biosig Technologies independently to ensure intended market timing strategies are aligned with expectations about Biosig Technologies volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biosig Technologies' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biosig Technologies' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Biosig Technologies Implied Volatility

Biosig Technologies' implied volatility exposes the market's sentiment of Biosig Technologies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biosig Technologies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biosig Technologies stock will not fluctuate a lot when Biosig Technologies' options are near their expiration.

Our Conclusion on Biosig Technologies

When is the right time to buy or sell Biosig Technologies? Buying stocks such as Biosig Technologies isn't very hard. However, what challenging for most investors is doing it at the right time. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities, deliver winning trades and diversify portfolios on a daily basis.
To conclude, as of the 24th of December 2021, our analysis shows that Biosig Technologies slowly supersedes the market. The company is undervalued and projects close to average probability of distress for the next 2 years. However, our primary 90 days buy vs. sell advice on the company is Strong Sell.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Biosig Technologies. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com